Danaher Corporation (0R2B.L)
| Previous close | 239.54 |
| Open | 240.47 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 239.90 - 240.47 |
| 52-week range | 182.16 - 269.23 |
| Volume | |
| Avg. volume | 37,092 |
| Market cap | 172.146B |
| Beta (5Y monthly) | 0.86 |
| PE ratio (TTM) | 0.28 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
Danaher Schedules Second Quarter 2024 Earnings Conference Call
Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2024 on Tuesday, July 23, 2024 beginning at 8:00 a.m. ET and lasting approximately one hour. During the call, the company will discuss its financial performance, as well as future expectations.
- PR Newswire
Danaher appoints Julie Sawyer Montgomery to Executive Vice President for Diagnostics
Danaher Corporation (NYSE: DHR) ("Danaher" or the "Company"), a leading global life sciences and diagnostics innovator, today announced that Julie Sawyer Montgomery will succeed Joakim Weidemanis as Executive Vice President, Diagnostics effective as of July 1, 2024. Mr. Weidemanis will support the transition over the next three months and will retire from Danaher on September 30, 2024 after 13 years of service.
- PR Newswire
Danaher Appoints Martin Stumpe to New Role of Chief Data & Artificial Intelligence Officer
Danaher Corporation (NYSE: DHR), a global science and technology innovator, today announced the creation of the new role of Chief Data & Artificial Intelligence (AI) Officer and the appointment of Dr. Martin Stumpe to the role.
